The 2024 Interdisciplinary Biomedical Research Symposium was held Saturday, Nov. 16, at A.T. Still University in ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-ß) Agonist, was Well-tolerated with Significant Reductions in Liver Fat at Week 12 in Non-cirrhotic MASH Patients in the Ongoing ...

TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...

Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...